Although TRAIL monotherapy seems to be inefficient for treatment of this type of cancer, our results highlight a possible applicability of platinum-based complexes in sensitization of prostate cancer cells to TRAIL-induced apoptosis. The gene discussed is TNFSF10; the disease is prostate cancer.